Multidrug Resistant Tuberculosis clinical trials

Explore recruiting multidrug resistant tuberculosis clinical trials.

Recruiting multidrug resistant tuberculosis studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Multidrug Resistant Tuberculosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Feasibility of the Application of a new Six-month Treatment for multidrug-resistant tuberculosis (MDR-TB) patients in France (FAST-MDR)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Evaluation of the early bactericidal activity of tedizolid and linezolide against Mycobacterium tuberculosis (TEDITUB)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Multidrug Resistant Tuberculosis trials by city

Multidrug Resistant Tuberculosis clinical trials

Recruiting multidrug resistant tuberculosis studies right now

Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB

Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis

Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment

Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)

A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB

Novel Triple-dose Tuberculosis Retreatment Regimen

Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment

Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis

Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)

A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

BPaL(M) Regimen for the Treatment of MDR/RR-TB

An Adaptive Randomized Controlled Trial

Also recruiting in Europe

Feasibility of the Application of a new Six-month Treatment for multidrug-resistant tuberculosis (MDR-TB) patients in France (FAST-MDR)

Evaluation of the early bactericidal activity of tedizolid and linezolide against Mycobacterium tuberculosis (TEDITUB)

Multidrug Resistant Tuberculosis trials by city

Other conditions